Tetramethylammonium Ion

Tetramethylammonium Ion

SCHEMBL2892487

C[N+](C)(C)C.N.[Br-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Tetramethylammonium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7655129-B2 Binding acceleration techniques for the detection of analytes OSMETECH TECHNOLOGY INC. (US) 2010-02-02 US disclosed
US-20080108074-A1 Methods and Compositions for Efficient Nucleic Acid Sequencing DRMANAC RADOJE T 2008-05-08 US disclosed
US-20080050393-A1 Novel nucleic acids and polypeptides NUVELO, INC. (A NEVADA CORPORATION) 2008-02-28 US disclosed
US-7087148-B1 Binding acceleration techniques for the detection of analytes CLINICAL MICRO SENSORS, INC. (US) 2006-08-08 US disclosed
US-7070927-B2 Methods and compositions for efficient nucleic acid sequencing UNIVERSITY OF CHICAGO (US) 2006-07-04 US disclosed
US-7001731-B2 Chemokine receptor obtained from a cDNA library of fetal liver-spleen NUVELO, INC. (US) 2006-02-21 US disclosed
US-6979548-B2 Chemokine receptor obtained from a CDNA library of fetal liver-spleen NUVELO, INC. (US) 2005-12-27 US disclosed
US-20050244954-A1 Binding acceleration techniques for the detection of analytes OSMETECH TECHNOLOGY INC. 2005-11-03 US disclosed
US-20050222393-A1 Antibody specific for a chemokine receptor; immunoassay and kits HYSEQ, INC. 2005-10-06 US disclosed
US-20050003399-A1 Binding acceleration techniques for the detection of analytes CLINICAL MICRO SENSORS, INC., (DBA OSMETECH TECHNOLOGY INC.) 2005-01-06 US disclosed
EP-1012335-A1 METHODS AND COMPOSITIONS FOR DETECTION OR QUANTIFICATION OF NUCLEIC ACID SPECIES HYSEQ, INC. (US) 2000-06-28 EP disclosed
WO-2000000515-A2 A CHEMOKINE RECEPTOR OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN HYSEQ, INC. (US) 2000-01-06 WO disclosed
EP-0968305-A1 METHODS AND COMPOSITIONS FOR DETECTION OR QUANTIFICATION OF NUCLEIC ACID SPECIES HYSEQ, INC. (US) 2000-01-05 EP disclosed
WO-1999067425-A2 BINDING ACCELERATION TECHNIQUES FOR THE DETECTION OF ANALYTES CLINICAL MICRO SENSORS, INC. (US) 1999-12-29 WO disclosed
WO-1999041382-A2 A NOVEL INTERLEUKIN-3 AND USES THEREOF HYSEQ, INC. (US) 1999-08-19 WO disclosed
WO-1999036567-A2 ENHANCED DISCRIMINATION OF PERFECT MATCHES FROM MISMATCHES USING A MODIFIED DNA LIGASE HYSEQ, INC. (US) 1999-07-22 WO disclosed
WO-1999009217-A1 METHODS AND COMPOSITIONS FOR DETECTION OR QUANTIFICATION OF NUCLEIC ACID SPECIES HYSEQ, INC. (US) 1999-02-25 WO disclosed
WO-1998031836-A1 METHODS AND COMPOSITIONS FOR DETECTION OR QUANTIFICATION OF NUCLEIC ACID SPECIES HYSEQ, INC. (US) 1998-07-23 WO disclosed
EP-0723598-A1 METHODS AND COMPOSITIONS FOR EFFICIENT NUCLEIC ACID SEQUENCING ARCH DEVELOPMENT CORPORATION (US) 1996-07-31 EP disclosed
WO-1995009248-A1 METHODS AND COMPOSITIONS FOR EFFICIENT NUCLEIC ACID SEQUENCING ARCH DEVELOPMENT CORP. (US) 1995-04-06 WO disclosed